 |
TheAnswerPage/Newborn Medicine
Monday
February 08, 2010
This week:
Polycythemia
|
Which patients should receive partial exchange
transfusion?
First, and most importantly, metabolic abnormalities should be
corrected, including hypoglycemia and hypocalcemia, and other less
common derangements, if present. The choice of which patients must be
treated remains somewhat controversial, but significant agreement
exists in several areas.
- If a baby has symptoms that could be related to
polycythemia/hyperviscosity, and the peripheral venous hematocrit
exceeds 65%, a partial exchange transfusion should be performed.
As noted in earlier questions, the timing, site, and method of
determination all affect the hematocrit, and partial exchange
transfusion may not in fact be indicated if there are untreated
causes of a late hematocrit elevation. For example, a newborn
might have an initial hematocrit of 60%, which rises to 66% after
36 hours of poor breastfeeding. At the time of hematocrit
determination, the baby is noted to be mildly hypoglycemic. Are
both factors related to dehydration, which can be more rapidly and
more appropriately corrected with hydration? If so, this is the
better choice of therapy.
- If a baby whose hematocrit (peripheral venous) is between 60
and 70% is without symptoms, they are usually managed by
maintaining adequate hydration and repeating the hematocrit 4 to 6
hours later. Overhydration or excessive volume infusion does not
make sense, if the baby is normally hydrated.
- If the hematocrit exceeds 70%, even if there are no symptoms,
a partial volume plasma exchange transfusion is usually indicated.
Some reports (1,2) suggest little or no significant benefit to the
procedure. Little data exists examining the impact of the
procedure in these infants with an extremely high hematocrit,
where the risk of excessive viscosity is almost certain. Thus, a
policy of treating asymptomatic infants in this apparently
high-risk group makes good sense.
How is partial exchange transfusion performed?
The procedure is usually accomplished using a "low" umbilical
venous catheter, placed to the point of blood return, which should
place the tip at about the level of the ductus venosus. Using this
catheter, the procedure can usually be accomplished as a single line
"push-pull" technique. If this method is not possible, two peripheral
venous catheters can be used instead. In either case, the goal is to
reduce the peripheral hematocrit to 50-55%, by exchanging a volume of
blood with saline. Use of adult plasma offers no benefit, and may
worsen viscosity (3). The volume, VE, for exchange (ml) is:
VE= Blood Volume * ((Observed Hct - Desired Hct)/Observed
Hct).
where
Blood Volume = Weight (kg) * 80-100 ml
The blood volume of most term infants is 80-100 ml/kg, but it may
be increased in polycythemic infants (4). Thus, the above formula
will only provide an approximate volume for exchange transfusion, as
the blood volume is estimated. In practice, the calculated volume
will be about 20 ml/kg, but a hematocrit should be determined about
an hour after the end of the procedure to ascertain success.
What are the risks of partial exchange transfusion?
The risks to the procedure include those associated with placing
and maintaining an umbilical venous catheter, including the risk of
thrombosis, embolism, or disruption of the vessel. The short-term
benefits of the procedure include amelioration of metabolic,
cardiovascular, and renal abnormalities, and improvement in acute and
minor neurologic symptoms. As discussed in previous questions, the
benefit in terms of improvement in long term neurologic function is
uncertain at best.
Reminder:
If you are a CME user and you logged in prior to reading this
question, don't forget to log out now!
References:
- Bada HS, Korones SB, Kolni HW, et al. Partial plasma exchange
transfusion improves cerebral hemodynamics in symptomatic neonatal
polycythemia. Am J Med Sci 1986; 29:157-163.
- Delaney-Black V, Camp BW, Lubchenco LO, et al. Neonatal
hyperviscosity association with lower school achievement and IQ
scores at school age. Pediatrics 1989; 83:662-667.
- Linderkamp O, Versold HT, Riegel KP, et al. Contribution of
red cells and plasma to blood viscosity in preterm and full-term
infants and adults. Pediatrics 1984; 74:45-51.
- Brans YW, Shannon DL, Ramamurthy RS. Neonatal polycythemia II.
Plasma, blood and red cell volume estimates in relation to
hematocrit levels and quality of intrauterine growth. Pediatrics
1981; 68:175-182.
Site Editor: Steven Ringer, M.D., Ph.D. Department of Department of Neonatology, Harvard Medical School
Founders
and Editors-in-Chief: Stephen B. Corn, M.D. and B. Scott Segal,
M.D.
Department of Anesthesiology, Perioperative and Pain Medicine, Harvard Medical School
|